AYTU logo

Aytu BioPharma (AYTU)

Profile

Full Name

Aytu BioPharma, Inc.

Ticker Symbol

AYTU

Exchange

NASDAQ

Country

United States

IPO

September 25, 2008

Indexes

Not included

Employees

102

Key Details

Price

$1.01(-0.97%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$81.00M(-24.58% YoY)

Annual EPS

-$2.86(+44.03% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Aug 9, 23 Maxim Group
Buy
May 31, 23 HC Wainwright & Co.
Buy
Jul 21, 22 HC Wainwright & Co.
Buy
May 17, 22 Cantor Fitzgerald
Overweight
Apr 28, 22 HC Wainwright & Co.
Buy
Mar 30, 21 Cantor Fitzgerald
Overweight
Nov 25, 20 Northland Securities
Outperform
Nov 25, 20 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Aytu BioPharma?
  • Does Aytu BioPharma pay dividends?
  • What sector is Aytu BioPharma in?
  • What industry is Aytu BioPharma in?
  • What country is Aytu BioPharma based in?
  • When did Aytu BioPharma go public?
  • Is Aytu BioPharma in the S&P 500?
  • Is Aytu BioPharma in the NASDAQ 100?
  • Is Aytu BioPharma in the Dow Jones?
  • When was Aytu BioPharma's last earnings report?
  • When does Aytu BioPharma report earnings?
  • Should I buy Aytu BioPharma stock now?

What is the ticker symbol for Aytu BioPharma?

The ticker symbol for Aytu BioPharma is NASDAQ:AYTU

Does Aytu BioPharma pay dividends?

No, Aytu BioPharma does not pay dividends

What sector is Aytu BioPharma in?

Aytu BioPharma is in the Healthcare sector

What industry is Aytu BioPharma in?

Aytu BioPharma is in the Drug Manufacturers - Specialty & Generic industry

What country is Aytu BioPharma based in?

Aytu BioPharma is headquartered in United States

When did Aytu BioPharma go public?

Aytu BioPharma's initial public offering (IPO) was on September 25, 2008

Is Aytu BioPharma in the S&P 500?

No, Aytu BioPharma is not included in the S&P 500 index

Is Aytu BioPharma in the NASDAQ 100?

No, Aytu BioPharma is not included in the NASDAQ 100 index

Is Aytu BioPharma in the Dow Jones?

No, Aytu BioPharma is not included in the Dow Jones index

When was Aytu BioPharma's last earnings report?

Aytu BioPharma's most recent earnings report was on Feb 12, 2025

When does Aytu BioPharma report earnings?

The next expected earnings date for Aytu BioPharma is May 15, 2025

Should I buy Aytu BioPharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page